TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
ADCT

ADC Therapeutics SA

Healthcare · Biotechnology

1.10$ +6.7% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADCT
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
97.5% 97.5% 94.4% 89.1% 87.7% 85.0% 88.6% 94.8% 95.5% 94.8%
92.6% 96.6% 92.2% 83.9% 85.5% 75.5% 66.5% 78.5% 77.9% 80.9%
92.6% 96.6% 92.2% 83.9% 85.5% 75.5% 66.5% 78.5% 77.9% 80.9%
3.8% 0.7% 0.2% 2.1% 0.5% 5.0% 14.9% 7.1% 6.3% 9.0%
0.1% 0.8% 1.8% 1.3% 1.8% 2.5% 4.6% 5.7% 1.3%
0.4% 1.0% 4.6% 0.9% 1.8% 2.0%
1.9% 2.0% 4.4% 6.1% 2.0% 2.2% 2.9%
9.1% 8.4% 16.1% 19.3% 34.7% 73.1% 83.8% 141.8% 162.9% 157.5%
6.2% 7.6% 14.8% 14.5% 7.9% 12.0% 16.7% 19.1% 25.0% 21.7%
0.8% 0.9% 1.2% 2.8% 0.4% 0.4% 0.9%
1.4% 2.8% 4.5% 2.4% 1.0% 2.0% 2.5% 4.4% 5.6% 2.8%
21.0% 20.2% 19.8% 31.8% 35.3% 34.8%
90.9% 91.6% 83.9% 80.7% 65.3% 26.9% 16.2% -41.8% -62.9% -57.5%
-76.8% -76.8% -220.6% -325.8% -135.3% -149.7% -223.2% -376.4% -463.8% -506.2%
21.6% 35.8% 48.6% 12.7% 12.4% 15.9% 23.0% 30.2% 39.3%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?